Published On: Thursday, July 21, 2022 | By: Team KnowMyStock
Gland Pharma sank 11 per cent after its consolidated net profit tumbled 35 per cent to Rs 229.2 crore on a 26 per cent decline in revenue from operations to Rs 856.9 crore in Q1 FY23 over last year.
Havells India slipped a per cent. The company posted a 3.5 per cent growth at Rs 241.581 crore in Q1 net profit for the quarter ended June 2022.
Follow Us On: